bluebird bio

$80$125

Bluebird Bio is biotechnology company engaged in researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases and cancer. The Company has built an integrated product platform with broad therapeutic potential in a variety of indications based on its lentiviral gene addition platform, gene editing and cancer immunotherapy capabilities. It offers various gene therapy programs including LentiGlobin for β-thalassemia; LentiGlobin for sickle cell disease; and Lenti-D for cerebral adrenoleukodystrophy.

Report ID:

UMHE21167

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21167 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Company Timeline
8.    Executive Team
9.    SWOT Analysis
10.    Key Financials
11. Recent Developments
11.1 Partnerships
11.2 Business Expansions & Investments “

Companies Mentioned

“Bristol Myers Squibb
Inhibrx, Inc.”